financetom
Business
financetom
/
Business
/
Monolithic Power Systems Insider Sold Shares Worth $2,443,032, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Monolithic Power Systems Insider Sold Shares Worth $2,443,032, According to a Recent SEC Filing
Sep 4, 2025 12:34 AM

03:16 AM EDT, 09/04/2025 (MT Newswires) -- Theodore Blegen, Chief Financial Officer and Executive Vice President, on September 02, 2025, sold 3,000 shares in Monolithic Power Systems ( MPWR ) for $2,443,032. Following the Form 4 filing with the SEC, Blegen has control over a total of 51,601 common shares of the company, with 40,939 shares held directly and 10,662 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1280452/000121465925013303/xslF345X05/marketforms-70492.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Li Auto Stock Today?
What's Going On With Li Auto Stock Today?
Jan 17, 2025
Li Auto Inc. ( LI ) shares are trading higher on Friday. In fact, shares of Chinese stocks are trading higher after China’s 2024 GDP met the government’s 5% target. According to Benzinga Pro, LI stock has lost over 22% in the past year. Investors can gain exposure to the stock via VanEck Low Carbon Energy ETF ( SMOG ) . Li...
What's Going On With Snap Stock Friday?
What's Going On With Snap Stock Friday?
Jan 17, 2025
Snap Inc. ( SNAP ) shares are trading lower on Friday despite the United States Supreme Court upholding the TikTok ban-or-sale law. Here’s what you need to know. What To Know: The court, in a unanimous decision, ruled that the law does not violate Americans’ First Amendment rights. To avoid the ban, TikTok would need to divest its U.S. assets,...
US FDA approves AstraZeneca's drug for breast cancer
US FDA approves AstraZeneca's drug for breast cancer
Jan 17, 2025
Jan 17 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca ( AZN ) and partner Daiichi Sankyo's ( DSKYF ) precision drug to treat a type of breast cancer, the health regulator said on Friday. (Reporting by Sriparna Roy in Bengaluru; Editing by Devika Syamnath) ...
GSI Technology Wins US Army Contract to Develop Edge AI Tools; Shares Rise
GSI Technology Wins US Army Contract to Develop Edge AI Tools; Shares Rise
Jan 17, 2025
01:28 PM EST, 01/17/2025 (MT Newswires) -- GSI Technology ( GSIT ) said Friday it has been selected by the US Army for a contract potentially valued up to $250,000 to create advanced edge computing artificial intelligence applications with its Gemini-II technology. The project, which is under the Small Business Innovation Research, or SBIR, program, seeks to integrate Gemini-II with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved